
Earning Supplement
Medifast® Q3 2026 Financial Highlights
Revenue and EPS within Guidance Range
Gross Profit Margin of 69.5% consistent with Q3 2025
Operating Loss increased versus Q3 2025, reflecting restructuring initiatives in the current quarter
Coach Productivity grew Y/Y for the fourth consecutive quarter
Revenue per active earning coach (AEC) increased 54% Y/Y & 8% Q/Q, and is expected to continue to grow throughout the remainder of 2026
Debt-Free, with $173 Million of Cash & Investments as of September 30, 2026, compared to $167M at December 31, 2025
Enterprise Value remains below net cash & investments
3
© 2026 Medifast, Inc. All Rights Reserved.
| Q3 2026 - By the Numbers$72M revenue | $160M working capital | ($1.57) ($0.19) GAAP Non-GAAP loss per share loss per share |
$7,064 revenue per active earning coach | 10,200 active earning coaches | $173M cash & cash equivalents and investments |
Coach Productivity
§ Expected to continue to rise throughout 2026 |
Productivity Improvements Historically Precede Coach & Revenue Growth
|
Percent of Coach Base Qualifying for Coach Leadership Level
|
At the McKinsey and Stanford Medicine Metabolic Health Business Building Summit 2026, panelists sized the existing metabolic health market at $12 trillion, with an additional $16 trillion in prevention and optimization that is still largely untapped.
Foundational Approach to GrowthSPEED
SIMPLICITY
SCALE
STEWARDSHIP
Science-Driven Innovation
Coaches at the Center
Enhanced Business Model
45+ years of scientific heritage
Once-in-a-generation opportunity to redefine wellness, as 90%+ US adults are metabolically unhealthy*
Targeting visceral fat reduction, lean mass retention, and healthy muscle protection
Not just measured by pounds lost, but by how much healthier a person becomes
Products launched in 2026 with clinically studied ingredients to support metabolic health
Human connection is core to approach
+
Coaches translate underlying science into real-world results
Clinical data shows clients who work with a coach lose 10x more weight** and 17x more fat** than those who go it alone
New compensation plan combines incentives, best practices, and recognition to help coaches grow their businesses
Trilivy Coach Hub and Business Blueprint to educate and support
A 10-year plan through 2036 to drive innovation and advance optimal health and wellbeing
+
A disciplined focus on speed, simplicity, scale, and stewardship
An ecosystem built to support clients across their whole health journey - expanding the market served
HSA/FSA eligibility on select plans that makes the solution more affordable for more clients†
*O'Hearn M, et al. Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. J Am Coll Cardiol. 2022;80(2):138-151. doi: 10.1016/j.jacc.2022.04.046.
**Those on the Reset 5 & 1 Plan with support of a coach successfully lost 10x more weight and 17x more fat than those who tried to lose weight on their own. Arterburn LM, et al. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. 2018;5(1):3-14. doi: 10.1002/osp4.312.
†Available for reimbursement on select insurance plans using Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA)
New Brand:
Launch of the new brand saw increased engagement across our digital properties
+468%Post Engagements
+126%Post Likes
+27%
Website Traffic
Slide to become social and marketing traction slide for Trilivy
Updated
I'm not really sure what the small images are doing for this slide. Alt version following this one.
*July 2026 compared to June 2026
© 2026 Medifast, Inc. All Rights Reserved.
8
Coach Hub
Coach Leadership Belief in the BusinessIncreased Field Leadership Energy & Engagement
Select group of coach leaders raising their hands to help lead the future growth of the business
Coach leaders are taking greater ownership of building the business alongside the company
Members of the cohort are investing their own capital through ownership in the company
Energy seen at recent events including Trilivy Leadership Symposium and NYSE closing bell ringing
Dr. Wayne Scott Andersen playing an active leadership role in the coach community
Created by a group of top Field leaders
Central location where new and existing coaches learn how to put the Trilivy Business Blueprint into practice
The Blueprint sets out what to do, in six core fundamentals running from identifying clients through to onboarding and coaching
Trilivy Coach Certification sets a consistent standard of knowledge across the Field
As coaches reach Executive Director and teach new coaches to do the same, the flywheel grows the business
Metabolic Synchronization®: Medifast's Breakthrough Scientific Framework
Metabolic Synchronization
Outcomes
→
Targets the root of metabolic dysfunction to improve metabolic health beyond weight loss
Systematic harmonization of the body's metabolic processes at the cellular level
Works with the body to help reset key metabolic processes that have fallen out of balance
Guides future research & innovation focus, which could include energy regulation, muscle health and performance, digestive health, metabolic health, sleep quality, and health span
Delivers strong & targeted fat burn, creating conditions for improvement in body composition, energy, & overall health
14%
visceral fat reduction*
Reduce98%
lean mass retention*
+
Retain
Lean Mass
+
Protect
Healthy Muscle
High-Quality Protein products & plans
Visceral (Bad) Fat
Lustig RH, et al. Obesity I: Overview and molecular and biochemical mechanisms. Biochem Pharmacol. 2022;199:115012. doi: 10.1016/j.bcp.2022.115012.
*Arterburn LM, et al. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. 2018;5(1):3-14. doi: 10.1002/osp4.312. In a clinical study, individuals on the Reset 5 & 1 Plan, retained 98% of lean mass and achieved 14% reduction of visceral fat at 16 weeks."
te
Medifast Metabolic Health Institu Core Pillars: Optimal Metabolic Health
Metabolic Health Science
Metabolic Health Research
Products Research & Development
Scientific Advisory Board
Scientific Communications
Education, Training & Certification
→
Advancing the field through rigorous research
Strengthening the evidence and benefits of healthy habits
Translating science into actionable knowledge
Driving advancements in optimal metabolic health
Through the Medifast Metabolic Health Institute, the company is:Elevating the importance of metabolic health as a cornerstone of well-being
Becoming a trusted source of metabolic health expertise
y
Now With The New MetaVantage Technolog
Clinically studied postbiotic helps support a reduced waist circumference*
Enhanced Product Line Launched: Upgraded for Optimal Metabolic HealthNutrition Blueprint
Nutrient-dense
High-quality complete protein
Interchangeable
24 essential vitamins & minerals
Prebiotics & probiotics
No flavors, colors, or sweeteners from artificial sources
Chromium picolinate helps maintain healthy insulin function
Choline
supports normal fat metabolism
+
*Pedret, A., R.M. Valls, L. Calderon-Perez, et al. Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial. Int J Obes (Lond) 2019;43(9):1863-1868.
Strong Start for Trilivy Product LineLaunched 31 Trilivy SKUs, representing
69%of the essential portfolio
Positioned the remaining Essential portfolio for continued transition through year-end 95%of our AECs in September sold Trilivy Products
Expanded the portfolio with Pumpkin Spice Bite Mix, a new seasonal product innovation13
© 2026 Medifast, Inc. All Rights Reserved.
© 2026 Medifast, Inc. All Rights Reserved.
Looking Ahead
Building for Sustainable GrowthConsistent & Clear Strategy Science-based, coach-guided system, executing a 10-year roadmap to help people achieve long-term metabolic health |
New Brand & Products
|
Coaches at the Center, Energized by New Compensation Plan
|
Market Opportunity is Significant
|
Operating Momentum & Disciplined Execution
|
© 2026 Medifast, Inc. All Rights Reserved.
© 2026 Medifast, Inc. All Rights Reserved.
*O'Hearn M, et al. Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. J Am Coll Cardiol. 2022;80(2): 138-151. doi: 10.1016/j.jacc.2022.04.046.
14
**Noubiap, J.J., Nansseu, J.R., Nyaga, U.F. et al. Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun 17, 573 (2026).
| 2026 - GAAP GuidanceQ4 2026 | $55M - $75M Q4 revenue | $0.00 - $0.25 Q4 income per share |
FY 2026 | $280M - $300M FY revenue | ($1.80) - ($2.05) FY loss per share |
Q4 2026 | $2M - $6M Adjusted EBITDA excluding interest income | $0.00 - $0.25 Q4 Non-GAAP income per share |
FY 2026 | $10M - $14M Adjusted EBITDA excluding interest income | ($0.45) - ($0.70) FY Non-GAAP loss per share |
Three Months Ended September 30, 2026 Restructuring and related GAAP charges Non-GAAP (Catalyst Restructuring) | |||
Cost of sales | $ 22,008 | $ (1,638) | $ 20,370 |
Gross profit | 50,040 | 1,638 | 51,678 |
Selling, general, and administrative | 69,398 | (13,768) | 55,630 |
Income (loss) from operations | (19,358) | 15,406 | (3,952) |
Other income | 1,523 | - | 1,523 |
Benefit for income taxes | (324) | - | (324) |
Net income (loss) | (17,511) | 15,406 | (2,105) |
Diluted earnings (loss) per share (1) | (1.57) | 1.38 | (0.19) |
Three Months Ended Three Months Ended September 30, 2026 September 30, 2025 | ||
Reconciliation from Net income to Adjusted EBITDA and Adjusted EBITDA excluding interest income: | ||
Net loss | $ (17,511) $ | (2,261) |
Interest income | (1,508) | (1,426) |
Benefit for income taxes | (324) | (396) |
Depreciation and amortization expense | 4,276 | 3,452 |
EBITDA | (15,067) | (631) |
Stock-based compensation expense | 1,850 | 910 |
Restructuring and related charges (Catalyst Restructuring), excluding depreciation and stock compensation | 13,579 | - |
Adjusted EBITDA | 362 | 279 |
Interest income | 1,508 | 1,426 |
Adjusted EBITDA excluding interest income | $ 1,870 $ | 1,705 |
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |

